Startups
StarFish Medical provides award-winning design, development, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Cardiovascular, Digital Health, IVD, Ophthalmology, Optics, and Ultrasound. StarFish expertise includes electronics, mechanical, human factors and software systems engineering.
Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in an ISO 13485 certified facilities with cleanroom capabilities in Toronto and Victoria.
Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485.
Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in an ISO 13485 certified facilities with cleanroom capabilities in Toronto and Victoria.
Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485.
Overview
Location
Canada, British Columbia, Victoria
Employees
51-200
Phone
+1 250-388-3537
Founded date
1998
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 16, 2022 | ViVitro Labs Introduces World's first "Set it and forget it" Heart Valve Durability Tester | New Heart Valve Durability tester with Automatic Dual Control technology debuts at the 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. "Introducing a New ... |
| Jan 11, 2021 | UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure | Lori Arakaki, Opticyte co-founder and CEO. (Opticyte Photo) University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The Seattle startup is developing a non-invasive techn... |
Reviews 0
FAQ about StarFish Medical
When was StarFish Medical founded?
StarFish Medical was founded in 1998.
What has the press written about StarFish Medical?
Parsers VC has collected 3 articles mentioning StarFish Medical, among them “ViVitro Labs Introduces World's first "Set it and forget it" Heart Valve Durability Tester” (Sep 16, 2022) and “UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure” (Jan 11, 2021).
Is StarFish Medical still active?
Yes, StarFish Medical is active; its latest activity on Parsers VC dates from Nov 5, 2024.